Clinical trials
Recruiting Observational Autoimmune Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 9 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Imagine Institute | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Scientific Institute San Raffaele | 2 |
| University Hospital, Brest | 2 |
| University Hospital, Montpellier | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| AndHealth | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 47 |
| Lupus Erythematosus, Systemic | 8 |
| Arthritis, Psoriatic | 6 |
| Arthritis, Rheumatoid | 6 |
| Immune System Diseases | 5 |
| Immunologic Deficiency Syndromes | 5 |
| Neoplasms | 5 |
| Psoriasis | 4 |
| Sjogren's Syndrome | 4 |
| Spondylitis, Ankylosing | 4 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.